{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:45Z","timestamp":1786119285569,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1097\/01.mbc.0000224853.50248.6f","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T08:01:54Z","timestamp":1146470514000},"page":"317-322","source":"Crossref","is-referenced-by-count":5,"title":["Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case report"],"prefix":"10.1097","volume":"17","author":[{"given":"Minoru","family":"Inagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Ambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000441-199808000-00002","article-title":"Congenital disorders of platelet function: disorders of signal transduction and secretion","volume":"316","author":"Rao","year":"1998","journal-title":"Am J Med Sci"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2002-27820","article-title":"Laboratory diagnosis of congenital von Willebrand disease","volume":"28","author":"Budde","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"R3-14-20210203","first-page":"333","article-title":"Molecular defects of platelets in Bernard-Soulier syndrome","volume":"9","author":"Nurden","year":"1983","journal-title":"Blood Cells"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0925-4439(03)00125-X","article-title":"Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bbeta-chain gene","volume":"1639","author":"Spena","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0268-960X(02)00030-9","article-title":"Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment","volume":"16","author":"Bellucci","year":"2002","journal-title":"Blood Rev"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-0037-1616221","article-title":"Hermansky\u2013Pudlak syndrome and Chediak\u2013Higashi syndrome: disorders of vesicle formation and trafficking","volume":"86","author":"Huizing","year":"2001","journal-title":"Thromb Haemost"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(03)00117-3","article-title":"Inherited bleeding disorders: disorders of platelet adhesion and aggregation","volume":"49","author":"Ramasamy","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"R8-14-20210203","first-page":"312","article-title":"Scott syndrome: a disorder of platelet coagulant activity","volume":"31","author":"Weiss","year":"1994","journal-title":"Semin Hematol"},{"issue":"Suppl 1","key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2516.2000.00056.x","article-title":"Platelet function disorders","volume":"6","author":"Shapiro","year":"2000","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/00001721-200405001-00009","article-title":"Non-accidental injury and the haematologist: the causes and investigation of easy bruising","volume":"15","author":"Liesner","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0889-8588(18)30506-9","article-title":"Congenital disorders of platelet function","volume":"4","author":"Rao","year":"1990","journal-title":"Hematol Oncol Clin North Am"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","article-title":"The use of recombinant factor VIIa in children with inherited platelet function disorders","volume":"121","author":"Almeida","year":"2003","journal-title":"Br J Haematol"},{"key":"R13-14-20210203","first-page":"981","article-title":"A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa","volume":"75","author":"Tengborn","year":"1996","journal-title":"Thromb Haemost"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0037-1963(01)90143-X","article-title":"Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia","volume":"38","author":"Poon","year":"2001","journal-title":"Semin Hematol"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200302000-00011","article-title":"Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia","volume":"14","author":"Chuansumrit","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-14-20210203","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","article-title":"Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia","volume":"94","author":"Poon","year":"1999","journal-title":"Blood"},{"key":"R17-14-20210203","first-page":"1","article-title":"The adhesiveness of human blood platelets in vitro","volume":"12","author":"Hellem","year":"1960","journal-title":"Scand J Clin Lab Invest"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2003-07-2287","article-title":"Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue-factor independent fibrin generation","volume":"103","author":"Lisman","year":"2004","journal-title":"Blood"},{"key":"R19-14-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"key":"R20-14-20210203","first-page":"431","article-title":"Recombinant activated factor VII for adjunctive hemorrhage control in trauma","volume":"51","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"key":"R21-14-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.SMJ.0000047629.79538.82","article-title":"Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients","volume":"96","author":"Tobias","year":"2003","journal-title":"South Med J"},{"key":"R22-14-20210203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1213\/00000539-200108000-00009","article-title":"An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII","volume":"93","author":"Hendriks","year":"2001","journal-title":"Anesth Analg"},{"key":"R23-14-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","article-title":"Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R24-14-20210203","first-page":"159","article-title":"Clinical experience with recombinant factor VIIa in patients with thrombocytopenia","volume":"26","author":"Kristensen","year":"1996","journal-title":"Haemostasis"},{"issue":"Suppl 1","key":"R25-14-20210203","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00001721-200004001-00013","article-title":"Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group","volume":"11","author":"Poon","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R26-14-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2141.1999.01128.x","article-title":"Home treatment with recombinant activated factor in patients with factor VIII inhibitors: the advantages of early intervention","volume":"104","author":"Santagostino","year":"1999","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"R27-14-20210203","first-page":"S15","article-title":"A possible mechanism of action of activated factor VII independent of tissue factor","volume":"9","author":"Monroe","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R28-14-20210203","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1016\/S0021-9258(17)37396-9","article-title":"Localization and characterization of an alpha-thrombin-binding on platelet glycoprotein Ib alpha","volume":"269","author":"Marco","year":"1994","journal-title":"J Biol Chem"},{"key":"R29-14-20210203","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood.V96.7.2469","article-title":"The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity","volume":"96","author":"Dormann","year":"2000","journal-title":"Blood"},{"key":"R30-14-20210203","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1074\/jbc.M008160200","article-title":"Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets","volume":"276","author":"De Candia","year":"2001","journal-title":"J Biol Chem"},{"key":"R31-14-20210203","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"R32-14-20210203","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.96.23.13336","article-title":"Increased thrombin responsiveness in platelets from mice lacking glycoprotein V","volume":"96","author":"Ramakrishnan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-14-20210203","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1073\/pnas.98.4.1823","article-title":"A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V","volume":"98","author":"Ramakrishnan","year":"2001","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200606000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:31Z","timestamp":1786039111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200606000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000224853.50248.6f","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}